Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-20094 in Type 2 Diabetes Mellitus (Phase II)
CTR20240352Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of olatorepatide in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Feb 2024; status: completed.
02
Drugs
olatorepatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240352.